Latest Information Update: 12 Nov 1999
At a glance
- Originator Ergo Science
- Class Anorectics
- Mechanism of Action Dopamine receptor agonists; Dopamine receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Obesity
Most Recent Events
- 12 Nov 1999 Discontinued-Preclinical for Obesity in USA (Unknown route)
- 14 Sep 1998 No-Development-Reported for Obesity in USA (Unknown route)
- 16 Jan 1996 New profile